UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 29, 2023
Accession Number: 0001193125-23-175090
Submission Type: POS AM
CIK: 0000891293
Company Name: CTI BIOPHARMA CORP
File Number: 333-221382